ESSA Pharma's total assets for Q3 2025 were $110.50M, a decrease of -4.26% from the previous quarter. EPIX total liabilities were $1.60M for the fiscal quarter, a -14.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.